Effect of food on the bioavailability of triclabendazole in patients with fascioliasis-Reference-Cited by-同舟云学术

Effect of food on the bioavailability of triclabendazole in patients with fascioliasis

Published:1998-06 Issue:6 Volume:45 Page:601-604
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Lecaillon J. B.¹,Godbillon J.¹,Campestrini J.¹,Naquira C.²,Miranda L.³,Pacheco R.⁴,Mull R.⁵,Poltera A. A.⁶

Affiliation:

1. Novartis Pharma S.A., Drug Metabolism & Pharmacokinetics, Rueil‐Malmaison, France,

2. Universidad Nacional Mayor de San Marcos, Instituto de Medicina Tropical ‘Daniel A. Carrion’, Parasitology Section, Lima, Peru,

3. Faculty of Medicine, Universidad Nacional San Antonio Abad del Cuzco, Peru,

4. Faculty of Biological Sciences, Universidad Nacional San Antonio Abad del Cuzco, Peru,

5. Novartis Pharma AG, Clinical Research, Basle, Switzerland,

6. Medizinische Abteilung Schweiz. Serum‐ and Impfinstitut, Bern, Switzerland. Formerly : Special Projects, Department of Medicine Ciba‐Geigy, Basle, Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2125.1998.00725.x

Reference13 articles.

1. Fasciola hepatica: Action in vitro of triclabendazole on immature and adult stages

2. Triclabendazole.;Robinson CP;Drugs Today,1985

3. Progress in assessment of the morbidity due to Fasciola hepatica infection: A review of the recent literature.;Chen MG;Trop Dis Bull,1990

4. LoutanL BouvierM RojanawisutB et al.Single treatment of invasive Fascioliasis with triclabendazole.Lancet1989;8659:383

5. Therapeutic effect of triclabendazole in patients with paragonimiasis in Cameroon: a pilot study

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fosfatriclaben, a prodrug of triclabendazole: Preparation, stability, and fasciolicidal activity of three new intramuscular formulations;Veterinary Parasitology;2024-04

2. Fascioliasis;Advances in Experimental Medicine and Biology;2024

3. Effects of triclabendazole and its metabolite exposure on the heart‐rate–corrected QT intervals: A randomized, placebo‐ and positive‐controlled thorough QT study in healthy individuals;Clinical and Translational Science;2023-09-08

4. Development of a safe pediatric liquisolid self-nanoemulsifying system of triclabendazole for the treatment of fascioliasis;International Journal of Pharmaceutics;2022-10

5. Fascioliasis;Helminth Infections and their Impact on Global Public Health;2022